Raiffeisen Bank International’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
6,363
+105
+2% +$21.8K 0.02% 360
2026
Q1
$1.29M Buy
6,258
+4,708
+304% +$1.01M 0.02% 360
2025
Q4
$321K Sell
1,550
-83
-5% -$15.6K ﹤0.01% 452
2025
Q3
$252K Sell
1,633
-4,108
-72% -$635K ﹤0.01% 450
2025
Q2
$940K Buy
5,741
+494
+9% +$73.3K 0.01% 287
2025
Q1
$716K Buy
5,247
+381
+8% +$48.6K 0.01% 314
2024
Q4
$574K Buy
+4,866
New +$568K 0.01% 338

Other funds holding CAH

Raiffeisen Bank International's CAH Position: Q2 2026 in Review

Raiffeisen Bank International increased its Cardinal Health (CAH) stake by 1.7% in Q2 2026, buying an estimated $21.8K and bringing the position to 6,363 shares worth $1.5M. The position accounts for 0.02% of the portfolio, ranked #360.

Raiffeisen Bank International first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Raiffeisen Bank International held 6,363 shares of Cardinal Health worth $1.5M as of Q2 2026.
  • Raiffeisen Bank International bought 105 Cardinal Health shares in Q2 2026, an estimated $21.8K.
  • Cardinal Health made up 0.02% of Raiffeisen Bank International's portfolio in Q2 2026, its #360 holding.
  • Raiffeisen Bank International first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.